Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 25, 2007

New Type of Cholesterol Implicated in Heart Disease

  • A recent study suggests that high levels of intestinal chylomicron cholesterol could be the reason behind the estimated 50% of cardiovascular disease events that occur in the presence of normal LDL cholesterol levels.

    Nutritional scientists at the University of Alberta established a connection between high insulin levels and dysfunction of intestinal lipid metabolism in an animal model. They believe that impaired intestinal metabolic function plays a critical role in the development of cardiovascular disease.

    The investigators found that the excessive insulin slows the removal of chylomicrons, large lipoproteins, from the blood stream following a fatty meal. Chylomicrons transport dietary fat from the intestine to the rest of the body. Excessive insulin appears to alter the mechanics of blood vessel walls, allowing chylomicrons and cholesterol to build up in them.

    These findings imply that testing patients for have high chylomicrons could allow them to take advantage of dietary manipulation and emerging drugs that can target intestinal cholesterol and perhaps improve chylomicron metabolism to prevent heart disease, states Donna Vine, Ph.D., a nutritional scientist and co-author of the paper. The research was published in Atherosclerosis.


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »